ArticleBiomedical reports2021

Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis.

Małgorzata Guz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.